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Abstract
Background: The aim of this study was to identify the candidate genes of esophageal squamous cell carcinoma (ESCC).
Methods: Gene expression profiling of 17 ESCC samples and 17 adjacent normal samples, GSE20347, was downloaded
from Gene Expression Omnibus database. The raw data were preprocessed, and the differentially expressed genes
(DEGs) between ESCC and normal samples were identified by using SAM software (false discovery rate <0.001). Then,
the co-expression network of DEGs was constructed based on Pearson’s correlation test (r-value ≥0.8). Furthermore,
the topological properties of the co-expression network were analyzed through NetworkAnalyzer (default settings) of
Cytoscape. The expression fold changes of DEGs and topological properties were utilized to identify the candidate genes
of ESCC (Crin score >4), which were further analyzed based on DAVID functional enrichment analysis (P-value <0.05).
Results: A total of 1,063 DEGs were identified, including 490 up-regulated and 573 down-regulated DEGs. Then, the
co-expression network of DEGs was constructed, containing 999 nodes and 46,323 edges. Based on the expression fold
changes of DEGs and the topological properties of the co-expression network, DEGs were ranked, and the top 24 genes
were candidate genes of ESCC, such as CRISP3, EREG, CXCR2, and CRNN. Furthermore, the 24 genes were significantly
enriched in bio-functions regarding cell differentiation, glucan biosynthetic process and immune response.
Conclusion: The present study suggested that CRISP3, EREG, CXCR2, and CRNN might be causative genes of ESCC, and
play vital roles in the development of ESCC. However, further experimental studies are needed to confirm our results.
Keywords: Esophageal squamous cell carcinomas, Differentially expressed genes, Topological properties, Co-expression
network, Candidate genes
Background
Esophageal squamous cell carcinoma (ESCC) is the pre-
dominant histologic subtype of esophageal cancer, which
is characterized by high mortality rate and geographic
differences in incidence [1]. ESCC is a common malig-
nant cancer worldwide, especially in China [2]. Recently,
clinical therapies have been used to treat ESCC, such as
neoadjuvant chemoradiotherapy [3,4], surgery [5], and
combination therapy [6]. However, these approaches do
not increase survival rate of patients with ESCC. To
investigate novel therapies, a clear understanding of the
molecular pathogenesis of ESCC is required, to which
much effort has been made.
Microarray analysis has been widely used to investigate
gene expression in various diseases, such as breast tumors
[7], brain cancer [8], endometrial cancer [9], and renal
cell carcinoma [10]. In previous studies of ESCC, loss
of heterozygosity (LOH) and copy number alteration in
ESCC were identified by using microsatellite markers and
low- and high-density SNP arrays [11,12]. The differentially
expressed genes (DEGs) and microRNAs between ESCC
and normal squamous epithelia have been identified based
on microarray analysis [13,14]. Moreover, a comprehensive
survey of commonly inactivated tumor suppressor genes
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in ESCC was performed based on microarray analysis and
functional reactivation of silenced tumor suppressor genes
by 5-aza-2′-deoxycytidine and trichostatin [15]. Thus,
microarray analysis is a useful approach to identify key
genes involved in ESCC.
In our study, microarrays were utilized to identify the
DEGs between human ESCC samples and adjacent nor-
mal tissues samples. Then, the co-expression network of
DEGs was constructed, and the topological properties of
the co-expression network were analyzed. Additionally,
we built an integrated index to rank DEGs and identify
the candidate genes of ESCC. Furthermore, the relevant
functions of candidate genes were investigated. We
anticipate that our work can find key genes related with
ESCC, and provide new insights for target therapies.
Methods
Microarray data and preprocessing
The raw gene expression profile GSE20347 [2] was down-
loaded from the public functional genomics database
Gene Expression Omnibus (GEO, http://www.ncbi.nlm.
nih.gov/geo/). In total, 34 specimens were available,
including 17 human ESCC samples and 17 matched
adjacent normal tissues samples. None of the patients
with ESCC had received prior therapy, and informed
consent was obtained. Demographic and clinical infor-
mation were matched. The corresponding platform was
GPL571, [HG-U133A_2] Affymetrix Human Genome
U133A 2.0 Array. The background correction and nor-
malization of microarray data among chips were conducted
based on RMA (Robust Multiarray Averaging) method
[16]. When several probes were mapped to one gene,
their mean value was taken as the gene expression
value of this gene.
DEG screening
SAM 4.0 software [17] was used to screen out the DEGs
between ESCC and normal samples. SAM is a widely used
tool for DEG screening. The criterion for this analysis was
false discovery rate (FDR) <0.001.
Hierarchical clustering analysis of DEGs
To determine the specificity of DEGs between ESCC and
adjacent normal samples, the pheatmap package in R was
utilized to perform bidirectional hierarchical clustering
analysis (BHCA) [18,19]. Rationally, after BHCA, ESCC
and adjacent normal samples are supposed to be distin-
guished clearly by DEGs.
Constructing the co-expression network of DEGs
In organisms, biological functions are often based on the
interaction of several genes, and significantly co-expressed
genes are usually co-regulated and involved in the same or
similar biological processes and pathways [20]. In order
to identify the co-expressed DEGs in ESCC tissues, the
expression values of DEGs in each sample were abstracted,
and Pearson’s correlation test was used to calculate the
correlation coefficient (r-value) of DEGs. Higher P-value
represents stronger correlation between node ‘n’ and its
adjacent nodes, and only the co-expressed DEG pairs with
r-value ≥0.8 were utilized to construct the co-expression
network of DEGs, which was visualized by using Cytos-
cape [21].
Analyzing the topological properties of the co-expression
network
The topological properties (node degree and clustering
coefficient) of DEGs in the co-expression network were
analyzed based on NetworkAnalyzer of Cytoscape soft-
ware [22]. Node degree and clustering coefficient are
important topological properties of network. Node degree
‘kn’ is the number of nodes connected to node ‘n’, display-
ing the local centrality of this node in network. Higher
node degree represents stronger importance of a node for
the stability of network. Clustering coefficient of node ‘n’
is defined as:
Cn ¼ 2en= kn kn‐1ð Þ½ 
In this formula, ‘kn’ is the number of adjacent nodes,
and ‘en’ is the number of interconnections among adjacent
nodes. Representing the clustering degree of node ‘n’,
Cn is between 0 and 1, and higher Cn represents that
the adjacent nodes of node ‘n’ connected with each
other more closely.
DEG ranking and candidate gene identification
Candidate genes of ESCC could be identified by ranking
DEGs based on expression fold changes, node degrees,
and clustering coefficients in the co-expression network.
In this study, firstly, Z-transformation was performed to
transform three sets of data into Z-scores, which are
common standardized scores in statistics [23]. Secondly,
the ranking index of each DEG was calculated based on
the formula as follows:
Crin ¼ FCn þ degreen þ C ð1Þ
Here, Crin is the ranking index of gene ‘n’, FCn is the
expression fold change of gene ‘n’, degreen is the node
degree of gene ‘n’ in theco-expression network, and Cn is
the clustering coefficient of gene ‘n’ in the co-expression
network. Thirdly, the DEGs with Crin score >4 were de-
fined as candidate genes of ESCC.
Functional enrichment analysis
To reveal the biological process associated with ESCC,
gene ontology (GO) functional enrichment analysis was
performed for the candidate genes of ESCC based on
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the Database for Annotation, Visualization and Integrated
Discovery (DAVID) [24]. DAVID provides exploratory
visualization tools to promote functional classification.
In this study, the criterion for this analysis was a P-
value <0.05.
Results
Identification of DEGs and hierarchical clustering analysis
After preprocessing and DEG screening, 1,063 DEGs
(FDR <0.001) were identified between ESCC and adjacent
normal samples, including 490 up-regulated and 573
down-regulated DEGs. After BHCA, ESCC and adjacent
normal samples could be distinguished clearly by DEGs
(Figure 1).
Construction of the co-expression network
The r-values of DEG pairs were calculated based on
Pearson’s correlation test, and the co-expression network
of DEGs with r-value ≥0.8 were constructed (Additional
file 1). The co-expression network involved 999 nodes
(DEGs) and 46,323 edges (co-expression relationships),
Figure 1 Bidirectional hierarchical clustering analysis of differentially expressed genes. The green to red gradation represented the
changes of expression value from down-regulation to up-regulation.
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and it was further divided into two closely connected
large sub-networks.
DEG ranking and candidate gene identification
To identify the candidate genes of ESCC, we established
an integrated ranking index by integrating the expression
fold changes, node degrees, and clustering coefficients
of DEGs in the co-expression network. Consequently, a
total of 24 genes were candidate genes (Crin score >4)
of ESCC (Table 1), such as cysteine-rich secretory protein
3 (CRISP3), epiregulin (EREG), chemokine receptor 2
(CXCR2), and cornulin (CRNN).
Functional enrichment analysis
To understand the biological processes involving candidate
genes, GO functional enrichment analysis (P-value <0.05)
was performed. It was found that the 24 candidate genes
were significantly enriched in bio-functions regarding cell
differentiation, glucan biosynthetic process and immune
response, including epidermal cell differentiation, epithelial
cell differentiation, epidermis development, keratinocyte
differentiation, glucan biosynthetic process, and regulation
of immune response (Table 2).
Discussion
In the present study, we identified 1,063 DEGs between
ESCC and adjacent normal samples, including 490 up-
regulated and 573 down-regulated genes. Furthermore,
the co-expression network of DEGs was constructed,
consisting of 2 large sub-networks, 999 nodes, and 46,323
edges. Then, the expression fold changes, node degrees,
and clustering coefficients of DEGs in the co-expression
network were comprehensively analyzed to rank DEGs,
and 24 candidate genes of ESCC were identified.
Among the 24 candidate genes, the highest ranking
was CRISP3. It was originally discovered in human
neutrophilic granulocytes, and is a glycoprotein that
belongs to a family of cysteine-rich secretory proteins
(CRISPs) [25]. In previous studies, CRISP3 is found to
be overexpressed in prostate adenocarcinoma by using
quantitative real-time reverse-transcription-PCR [26].
Additionally, Su et al. reveal that CRISP3 is significantly
down-regulated in ESCC, and may be the biomarker of
ESCC [27]. Furthermore, CRISP3 was reported to be
down-regulated in oral squamous cell carcinoma (OSCC),
and the loss of its DNA copy number was observed in two
of the five OSCC-derived cell lines [28].
EREG was the second highest ranking of 24 candidate
genes whose protein product, EREG, induces cell growth
by binding to the epidermal growth factor receptor (EGFR)
[29]. It is reported that EREG is epigenetically silenced
in gastric cancer cells by aberrant DNA methylation and
histone modification [29]. Moreover, EREG is involved
in the invasion and metastasis of esophageal carcinoma
by combining with sphingosine kinase-1 (SPHK1) [30].
CXCR2I codes a receptor of ELR + CXC chemokines,
which are potent promoters of angiogenesis [31]. It is re-
ported that GROA-C XCR2 and GROB-C XCR2 signal-
ing contribute significantly to esophageal cancer cell
proliferation, and this autocrine signaling pathway may
be involved in esophageal tumorigenesis [32,33].
CRNN codes cornulin, a Ca2+ − binding protein that
presents in the upper layer of squamous epithelia [34]. It
has been shown that the large majority of ESCC cases
have little or no expression of cornulin in carcinoma or
stromal cells [35]. These evidences suggested that CRISP3,
Table 1 The 24 candidate genes of esophageal squamous
cell carcinomas
Rank Symbol Rank Symbol
1 CRISP3 13 CYP4B1
2 EREG 14 SLURP1
3 ENDOU 15 MAL
4 CXCR2 16 TGM3
5 CRCT1 17 CWH43
6 FLG 18 TMPRSS11E
7 CLIC3 19 CLCA4
8 CRNN 20 PPP1R3C
9 MMP1 21 BBOX1
10 GYS2 22 HPGD
11 EPB41L3 23 SPINK5
12 SCEL 24 FCER1A
Table 2 Functional enrichment analysis of the 24 candidate
genes
GO ID GO term P-value
GO:0009913 Epidermal cell differentiation 2.43E-06
GO:0030855 Epithelial cell differentiation 3.14E-05
GO:0008544 Epidermis development 9.93E-05
GO:0030216 Keratinocyte differentiation 1.10E-04
GO:0008544 Epidermis development 1.21E-04
GO:0007398 Ectoderm development 1.34E-04
GO:0060429 Epithelium development 2.23E-04
GO:0009888 Tissue development 1.15E-02
GO:0009250 Glucan biosynthetic process 1.70E-02
GO:0005978 Glycogen biosynthetic process 1.70E-02
GO:0033692 Cellular polysaccharide biosynthetic process 3.54E-02
GO:0050776 Regulation of immune response 4.14E-02
GO:0044042 Glucan metabolic process 4.87E-02
GO:0006073 Cellular glucan metabolic process 4.87E-02
GO:0009913 Epidermal cell differentiation 2.43E-06
GO:0030855 Epithelial cell differentiation 3.14E-05
GO: gene ontology; ID: identifier.
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EREG, CXCR2, and CRNN may play crucial roles in ESCC,
as well as other candidate genes.
In addition, GO functional enrichment analysis was
performed, and some biological processes were enriched
significantly, such as epidermal cell differentiation, epithelial
cell differentiation, epidermis development, keratinocyte
differentiation, and regulation of the immune response. It
has been shown that proliferation and development of
esophageal epithelial cells are associated with the develop-
ment of ESCC [36]. Moreover, ESCC-related gene modules
are significantly enriched in epidermal cell differentiation,
epithelial cell differentiation, epidermis development, and
keratinocyte differentiation [37]. Additionally, keratinocytes
migrate from the basal to the superficial layers of the
epidermis, and undergo morphological and biochemical
changes during terminal differentiation, which are involved
in the development of ESCC [38,39]. Our results were
consistent with these evidences.
Conclusions
In conclusion, the DEGs between ESCC and adjacent
normal tissues were screened out, and the co-expression
network was constructed, consisting of 2 large sub-
networks, 999 nodes, and 46,323 edges. After analyzing
the gene expression and topological properties of DEGs
in the co-expression network, DEGs were ranked, and
24 candidate genes of ESCC were identified. Candidate
genes, such as CRISP3, EREG, CXCR2, and CRNN, were
identified as potentially playing key roles in the develop-
ment of ESCC. Furthermore, functional enrichment
analysis revealed that the 24 genes were mainly enriched
in epithelial cell differentiation, epidermis development,
and keratinocyte differentiation. These results provided us
with candidate genes and demonstrated their potential
functions in the development of ESCC. However, more
experimental studies are needed to confirm these results.
Additional file
Additional file 1: The co-expression network of differentially
expressed genes.
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